PROMOMED is a double-acting hepatoprotector
22.05.2020
Medicines
22.05.2020
Clinical trials of the drug "Areplivir", developed at Biochemistry, have begun in Mordovia.
It is expected that it will become the main medicine in the fight against the new coronavirus infection. The effectiveness of the active substance is being studied along with us in 29 other countries. The TV program Vesti (Russia 1) managed to get into the red zone of the covid hospital and listen to the opinions of patients, doctors and scientists about the "drug of hope".
Stay informed
Stay informed
Get the most interesting news and publications first!
Sent successfully!
Press office
To request a press release or interview, please contact our press office